Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Contact information


usha.singh@cmd.ox.ac.uk

Research groups

Usha Singh

Postdoctoral Scientist – Cancer Biology & Systems Pharmacology

I obtained my Master of Science in Biotechnology from Banasthali University, India. Following this, I pursued my PhD with the Nucleoporin & Sumo Biology Group at the Indian Institute of Science Education and Research, Bhopal, India. My doctoral research focused on elucidating the relationship between nucleoporin overexpression and its mechanistic role in cancer. Additionally, I investigated the biological functionality of protein modification and the chemistry of drug modification.

Subsequently, I worked as a postdoctoral fellow on a collaborative project between the National Centre for Cell Science, Pune, India, and Bharat Biotech International Limited, Hyderabad, India. In this role, we developed human neutralizing monoclonal antibodies against SARS-CoV-2.

In March 2022, I joined the Huber group as a postdoctoral scientist for an exciting translational project with Cancer Research UK and Merck. My current work focuses on elucidating the molecular dynamics of transcriptional complexes in cancer to develop novel drug targets.